Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 305 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 11/05/21
End: 11/05/24
Due: 11/05/25
Phase: N/A
Priority: Normal
Start: 05/22/23
End: 12/10/23
Due: 12/10/24
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 01/28/23
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 04/05/27
Due: 04/05/28
Phase: N/A
Priority: Normal
Start: 02/04/25
End: 06/04/25
Due: 06/04/26
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 08/04/21
End: 02/10/24
Due: 02/10/25
Phase: N/A
Priority: Normal
Start: 07/15/22
End: 01/15/23
Due: 01/15/24
Phase: N/A
Priority: Normal
Start: 11/20/18
End: 07/01/20
Due: 07/01/21
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 03/31/24
End: 11/30/26
Due: 11/30/27
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
Phase: N/A
Priority: Normal
Start: 06/20/25
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 12/26/20
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 04/09/25
End: 04/01/28
Due: 04/01/29
Phase: N/A
Priority: Normal
Start: 02/28/22
End: 12/05/24
Due: 12/05/25